CAS NO: | 849000-18-6 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Lu AE98134, an activator ofvoltage-gated sodium channels, acts as a partly selectiveNav1.1channelspositive modulator. Lu AE98134 also increases the activity ofNav1.2andNav1.5channels but not ofNav1.4,Nav1.6andNav1.7channels. Lu AE98134 can be used to analyze pathophysiological functions of theNav1.1channel in various central nervous system diseases, including cognitive restoring in schizophrenia, et al[1]. | ||||||||||||||||
体外研究 (In Vitro) | Lu AE98134 (30 μM) promotes the current mediated by Navv1.1 channel, and it activates Nav1.5 and to a lesser extent Nav1.2 but has no effect on Nav1.4, Nav1.6 and Nav1.7 currents in HEK cells expressing Nav1.1, Nav1.2, Nav1.6, Nav1.5, and Nav1.7 by step-wise depolarizing voltages using the whole-cell patchclamp configuration[1].Lu AE98134 (30 μM) increases the excitability of FSINs by decreasing the threshold for action potentials.Intracellular depolarizing current pulses evokes repetitive firing of action potentials at frequencies, additionally, Lu AE98134 increases the excitability since each current pulse generated a higher number of spikes (163 spikes in control; and 230 spikes in Lu AE98134)[1]. | ||||||||||||||||
体内研究 (In Vivo) | The fast spiking inhibitory interneurons (FSINs) from Dlx5/6+/–animals exhibit abnormal excitability because of a more depolarized spike threshold and broader action potentials.Lu AE98134 (30 μM) increases the excitability of FSINs neurons from normal and Dlx5/6+/–animals by modulating several parameters characteristic for NaV1.1channels. The selective activation of FSINs by Lu AE98134 restores cognitive flexibility in adult Dlx5/6+/–mice[1]. | ||||||||||||||||
分子量 | 425.50 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C21H23N5O3S | ||||||||||||||||
CAS 号 | 849000-18-6 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 250 mg/mL(587.54 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|